Note: Ingredients listed on restricted chemical lists
EC/CAS
58-55-9
Name of the chemical
Theophyllin; 1,3-Dimethyl-3,7-dihydro-1H-purin-2,6-dion (2022/692)
Concentration
60
EC/CAS
77-93-0
Name of the chemical
citric acid, triethyl ester
Concentration
1.09
EC/CAS
14807-96-6
Name of the chemical
Talc
Concentration
0.84
General Information
Revision date
2021-11-19
Product name
THEOVENT TABLETS 300
Product Synonyms
THEOVENT TABLETS 300 MG * THEOVENT 300 PROLONGATUM TABLETKI 300 MG *
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline Canada
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Danger
Section 2
Physical hazards
Not classified.
Health hazards
Acute toxicity, oral Category 3
Environmental hazards
Not classified.
Signal word
Danger
Hazard statements
Toxic if swallowed.
Prevention
Wash thoroughly after handling. Do not eat, drink or smoke when using this product.
Response
IF SWALLOWED: Immediately call a POISON CENTRE/doctor/. Rinse mouth. Specific treatment (see this label).
Storage
Store locked up.
Disposal
Not available.
2.3 Other hazards
Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
Additional information
25.2 % of the mixture consists of component(s) of unknown acute oral toxicity. 30.2 % of the mixture consists of component(s) of unknown acute dermal toxicity. 30.2 % of the mixture consists of component(s) of unknown acute inhalation toxicity. 31.29 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 31.29 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
